2017 Annual Meeting | C155 - Controversies in Stroke Therapy

Date Wednesday 04/26/17

Time 07:00 AM - 09:00 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Steven R. Messe, MD, FAHA, FAAN

Topic(s)

Learning Objectives Participants should be knowledgeable about the optimal management of acute cerebral infarction, including patient selection for thrombolytic treatment, endovascular therapy, and surgical interventions; and develop a logical framework for implementing various long-term vascular risk reduction strategies, including selection of antithrombotic agents, lipid modifiers, antihypertensive therapies, and revascularization procedures.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
07:00 AM - 07:05 AM	Luncheon	Introduction
07:05 AM - 07:50 AM	Speaker	Controversies in Acute Stroke Steven R. Messe, MD, FAHA, FAAN
07:50 AM - 08:35 AM	Speaker	Controversies in Stroke Prevention Tanya N. Turan, MD, FAAN
08:35 AM - 09:00 AM	Q&A	Questions and Cases

Faculty Disclosures
Steven R. Messe, MD, FAHA, FAAN	Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Terumo. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for WL Gore. The institution of Dr. Messe has received research support from WL Gore. The institution of Dr. Messe has received research support from Mallinkrodt. The institution of Dr. Messe has received research support from Biogen. Dr. Messe has received intellectual property interests from a discovery or technology relating to health care. Dr. Messe has received publishing royalties from a publication relating to health care. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving as a Clinical Event Committee for the CONFORMAL left atrial appendage occlusion trial with Yale Cardiovascular Research Group.
Tanya N. Turan, MD, FAAN	Dr. Turan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer/Merck. Dr. Turan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Gore Inc. Dr. Turan has received publishing royalties from a publication relating to health care. Dr. Turan has received publishing royalties from a publication relating to health care.

��ɫ��

��ɫ��